Manead Khin

PETRI DISH PERSPECTIVES

Science EN ↓ 71 episodes

Burma | Chicago Scientist 🥼🧪🔬 Covering biotech, pharma, and healthcare companies shaping the world 🧬🏥🌎 Stream new episodes every THURSDAY! https://linktr.ee/maneadkhin #biotech #pharma #healthcare #podcast #petridishperspectives

Author

Manead Khin

Category

Science

Latest episode

Jul 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Episode 21: Moderna 18.09.2025

Send us Fan Mail From secrecy and skepticism to one of the fastest vaccine rollouts in history, this episode of Petri Dish Perspectives: Biotech Unleashed dives into the remarkable journey of Moderna. We trace the company’s early hype, billion-dollar partnerships, and criticism for overpromising, through to its historic COVID-19 vaccine that changed global medicine. What’s next for Moderna beyond...

Episode 20: Baxter 11.09.2025

Send us Fan Mail Baxter may not always grab the biotech headlines, but its impact on modern healthcare is impossible to ignore. From the first commercially prepared IV solutions in the 1930s to pioneering dialysis fluids, blood systems, recombinant hemophilia therapies, and parenteral nutrition, Baxter has consistently solved medicine’s “unsexy but essential” problems. In this episode, we dive int...

Episode 19: AstraZeneca 04.09.2025

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , host Manead explores the remarkable journey of AstraZeneca , from its unlikely Swedish-British merger to blockbuster drugs like Nexium and Crestor, through near-decline, and ultimately its reinvention as a science-driven leader in oncology, cardiometabolic health, and global public health.  Discover how bold leadershi...

Episode 18: Gilead 28.08.2025

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we dive into the remarkable and controversial story of Gilead Sciences , a company that redefined what medicine could achieve. From its beginnings in the late 1980s under physician-scientist Michael Riordan, Gilead transformed antiviral drug development with breakthroughs in HIV treatment, revolutionized global health...

Episode 17: GSK 21.08.2025

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we dive into the story of GlaxoSmithKline (GSK), one of the world’s most influential pharma giants! From scaling up penicillin production in WWII, to pioneering semi-synthetic antibiotics like amoxicillin, to leading the global vaccine race with Cervarix and Shingrix, GSK has left an indelible mark on modern medicine....

Episode 16: Amgen 14.08.2025

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we dive deep into the origin story of Amgen , a company that helped turn “biotechnology” from a niche lab concept into a global medical force. We’ll trace Amgen’s unlikely beginnings in 1980, a time when gene splicing was still the stuff of scientific legend and meet the eclectic founding team: George Rathmann, the ch...

Episode 15: BGI Genomics 07.08.2025

Send us Fan Mail What happens when one of the world’s most powerful genomics companies rises from a college dorm in China and goes on to challenge the West’s biotech dominance? In this episode of Petri Dish Perspectives: Biotech Unleashed , we unravel the story of BGI Genomics , a company at the intersection of cutting-edge science, national ambition, and global controversy. From decoding the huma...

Episode 14: Abbott 31.07.2025

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , host Manead takes you inside the remarkable story of Abbott Laboratories: a company that doesn’t chase headlines but touches billions of lives every day. From its origins in 1888 as a small Chicago pharmacy mixing precise plant-based pills, Abbott has grown into a global healthcare powerhouse behind life-changing prod...

Episode 13: Sarepta 24.07.2025

Send us Fan Mail DISCLAIMER: This is a consistently changing situation. The episode was recorded approximately 4 PM EDT Monday, July 21, 2025.  As of 7.40 PM EDT Monday, July 21, 2025 (Source: Sarepta), "Sarepta Therapeutics notified the U.S. FDA of its decision to voluntarily and temporarily pause all shipments of ELEVIDYS (delandistrogene moxeparvovec) for Duchenne muscular dystrophy in the...

Episode 12: Vertex 17.07.2025

Send us Fan Mail 🔬✨ From Cystic Fibrosis Breakthroughs to Gene Editing Cures In this episode of Petri Dish Perspectives: Biotech Unleashed , Manead unpacks how Vertex turned cystic fibrosis from a fatal disease into a treatable condition and why they’re now tackling sickle cell, diabetes, and more with CRISPR and stem cell science. Discover how visionary chemists, Nobel-winning gene editors, and...

Episode 11: Genentech 10.07.2025

Send us Fan Mail 🧬 From VC to Blockbusters: The Genentech Story In Episode 11 of Petri Dish Perspectives: Biotech Unleashed , host Manead dives into the legendary rise of Genentech, the startup that sparked the biotech revolution. From its humble beginnings in a borrowed lab to pioneering insulin, tPA, Herceptin, and more, learn how Genentech turned recombinant DNA into real-world cures. Discover...

Episode 10: Roche 03.07.2025

Send us Fan Mail 💡 From Vitamin C to AI-Driven Diagnostics: Roche’s Legacy Unleashed In this episode of Petri Dish Perspectives: Biotech Unleashed , we explore the extraordinary evolution of Roche, from its origins as a 19th-century Swiss chemical company to becoming a global leader in pharmaceuticals and diagnostics. You’ll hear how Roche launched the world’s first branded vitamin C, pioneered m...

Episode 9: Bayer 26.06.2025

Send us Fan Mail 🎧 From Dye Pots to Blockbusters: The Bayer Story In this episode of Petri Dish Perspectives: Biotech Unleashed , host Manead takes you on a journey through Bayer’s 160+ year evolution, from its 1863 roots in coal tar dyes to becoming the maker of Aspirin 💊, Xarelto ❤️, and Eylea 👁️. We explore how a dye salesman and a master dyer built a pharma empire, the game-changing inventio...

Episode 8: Bristol Myers Squibb 19.06.2025

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we journey through the 165+ year saga of Bristol Myers Squibb (BMS) — from 19th-century Brooklyn apothecaries and sparkling laxatives 💊 to cutting-edge CAR-T therapies and checkpoint inhibitors in cancer treatment 🧫🔥. Host Manead, a PhD scientist in cancer biology and analytical chemistry, breaks down: 📜 The paral...

Episode 7: Sanofi 12.06.2025

Send us Fan Mail Ever wonder how an oil conglomerate helped create one of the world’s top pharma giants? 💥 In this episode of Petri Dish Perspectives: Biotech Unleashed , your host, Manead, dives into the fascinating story of Sanofi , a company whose name you’ve probably seen on insulin pens 💉, flu shots 🦠, and blockbuster immunology meds 💊. We explore:  🔹 Sanofi’s wild beginnings inside a Fr...

Episode 6: Merck 30.04.2025

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we'll take you on a 350-year journey through the rise of Merck, from its humble beginnings as a family-run pharmacy in 17th-century Germany to becoming one of the world’s most influential pharmaceutical powerhouses. We’ll explore how Merck evolved through groundbreaking discoveries like streptomycin, the MMR vacc...

Episode 5: Boehringer Ingelheim 09.04.2025

Send us Fan Mail 🐴 From Farmyard Roots to Pharma Powerhouse: The Boehringer Ingelheim Story 🐴 Welcome to Petri Dish Perspectives: Biotech Unleashed! 🚀 I’m your host, Manead—scientist and biotech nerd. Today, we’re spotlighting Boehringer Ingelheim—a family-owned pharma giant that began in a small German village and grew into one of the world’s top 20 pharmaceutical companies. From veterinary va...

Episode 4: Johnson & Johnson 02.04.2025

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we dive into the rich history and groundbreaking innovations of Johnson & Johnson (J&J) —one of the most influential healthcare companies in the world. From its origins in the late 19th century as a family-run surgical supply business to becoming a household name with products like Band-Aids , Tylenol , and Jo...

Episode 3: AbbVie 26.03.2025

Send us Fan Mail In this episode of Petri Dish Perspectives: Biotech Unleashed , we explore the rise of AbbVie , a pharmaceutical giant that emerged from Abbott Laboratories in 2013 and quickly became a leader in immunology, oncology, and aesthetics. From its blockbuster drug Humira to major acquisitions like Pharmacyclics and Allergan , AbbVie has strategically expanded its portfolio and global p...

Episode 2: Eli Lilly 20.03.2025

Send us Fan Mail Welcome to Petri Dish Perspectives: Biotech Unleashed ! In this episode, we dive deep into the history and impact of Eli Lilly , a company that began with a small lab in Indianapolis and has grown into the highest market-cap pharmaceutical company in the world . From pioneering insulin production in the 1920s to developing blockbuster drugs like Prozac, Humalog, and Mounjaro , Eli...

Episode 1: Pfizer 12.03.2025

Send us Fan Mail 💊 From Brooklyn to Biotech Titan: The Rise of Pfizer 💊 Welcome to the first-ever episode of Petri Dish Perspectives: Biotech Unleashed ! 🚀 I’m your host, Manead—scientist, biotech nerd, and your guide through the fascinating world of life sciences. We’re kicking things off with Pfizer —a company that started as a small chemical business in Brooklyn and grew into a global powerh...

Listen to the PETRI DISH PERSPECTIVES podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.